Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weifuchun in Precancerous Lesions of Gastric Cancer
NCT03814629Phase 1Unknown
- Sponsor
- Shuguang Hospital
- Start
- Aug 2015
- Primary completion
- Sep 2019
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of weifuchun in chronic atrophic gastritis (CAG) and gastric cancer (GC), sponsored by Shuguang Hospital. Primary endpoints: Histopathological change at 24 weeks and Gastroscopic change at 24 weeks. Status: unknown.
02
Drugs
weifuchun
03
Conditions
chronic atrophic gastritis (CAG)gastric cancer (GC)
Beyond the preview
Go deeper on NCT03814629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03814629.